Rochester, MN3 Active Studies

Myeloproliferative Neoplasms Clinical Trials in Rochester, MN

Find 3 actively recruiting myeloproliferative neoplasms clinical trials in Rochester, MN. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
291
Enrolling

Recruiting Myeloproliferative Neoplasms Studies in Rochester

About Myeloproliferative Neoplasms Clinical Trials in Rochester

Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.

There are currently 3 myeloproliferative neoplasms clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 291 participants. Research is being sponsored by Disc Medicine, Inc, Telios Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myeloproliferative Neoplasms Clinical Trials in Rochester — FAQ

Are there myeloproliferative neoplasms clinical trials in Rochester?

Yes, there are 3 myeloproliferative neoplasms clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What myeloproliferative neoplasms treatments are being tested?

The 3 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.

Data updated March 2, 2026 from ClinicalTrials.gov